Literature DB >> 591069

Serum and tissue lysozyme in leprosy.

T H Rea, C R Taylor.   

Abstract

Mean serum lysozyme values were found to be elevated in untreated leprosy patients. Statistically significant elevations were present in each of the three major categories of leprosy, tuberculoid, borderline, and lepromatous. Values were particularly high in patients with severe reversal reactions or Lucio's phenomenon. Prolonged sulfone therapy was associated with a fall in serum lysozyme values. With an immunoperoxidase method to localize lysozyme in leprous tissues, two distinct staining patterns were found, granular and saccular. The grandular pattern of lysozymal staining was found in epithelioid cells and in giant cells, and the intensity of staining showed a positive correlation with serum lysozyme levels. Conversely, a saccular pattern of lysozymal staining was found in lepromatous histiocytes, buth the intensity of staining was unrelated to serum lysozyme levels; the saccular structures contained dense aggregates of Mycobacterium leprae. These two patterns of staining probably represent different functional responses of monocyte-derived granuloma cells, whereas the serum levels reflect, to a varying degree, both the absolute number of such cells and the rate of secretory activity of this cell population as a whole.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591069      PMCID: PMC421311          DOI: 10.1128/iai.18.3.847-856.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  The demonstration of lysozyme as a dominant tuberculostatic factor in extracts of granulomatous lungs.

Authors:  S OSHIMA; Q N MYRVIK; E LEAKE
Journal:  Br J Exp Pathol       Date:  1961-04

Review 2.  Secretory function of mononuclear phagocytes: a review.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

3.  Elevation of serum angiotensin-converting enzyme in Gaucher's disease.

Authors:  J Lieberman; E Beutler
Journal:  N Engl J Med       Date:  1976-06-24       Impact factor: 91.245

4.  Serum lysozyme in Crohn's disease and ulcerative colitis.

Authors:  E Hylander; N E Hansen; H Karle; S Janrum
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

5.  A tuberculostatic serum substance possessing lysozyme-like properties.

Authors:  Q MYRVIK; R S WEISER
Journal:  Am Rev Tuberc       Date:  1951-12

6.  Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.

Authors:  B Myrvang; T Godal; D S Ridley; S S Fröland; Y K Song
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

7.  Serum lysozyme in pulmonary tuberculosis.

Authors:  P E Perillie; K Khan; S C Finch
Journal:  Am J Med Sci       Date:  1973-04       Impact factor: 2.378

8.  Plasma muramidase: a study of methods and clinical applications.

Authors:  S Zucker; D J Hanes; W R Vogler; R Z Eanes
Journal:  J Lab Clin Med       Date:  1970-01

9.  Increased circulating levels of transcobalamin ii in gaucher's disease.

Authors:  H S Gilbert; N Weinreb
Journal:  N Engl J Med       Date:  1976-11-11       Impact factor: 91.245

10.  THE PARTICULATE HYDROLASES OF MACROPHAGES. I. COMPARATIVE ENZYMOLOGY, ISOLATION, AND PROPERTIES.

Authors:  Z A COHN; E WIENER
Journal:  J Exp Med       Date:  1963-12-01       Impact factor: 14.307

View more
  11 in total

Review 1.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis.

Authors:  K A Near; M J Lefford
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  Altered monocyte function in patients with benign breast disease.

Authors:  A M Al-Sumidaie; S J Leinster; S A Jenkins
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

4.  Expression of adhesion molecules in leprosy lesions.

Authors:  L Sullivan; S Sano; C Pirmez; P Salgame; C Mueller; F Hofman; K Uyemura; T H Rea; B R Bloom; R L Modlin
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Authors:  Megan S Inkeles; Rosane Mb Teles; Delila Pouldar; Priscila R Andrade; Cressida A Madigan; David Lopez; Mike Ambrose; Mahdad Noursadeghi; Euzenir N Sarno; Thomas H Rea; Maria T Ochoa; M Luisa Iruela-Arispe; William R Swindell; Tom Hm Ottenhoff; Annemieke Geluk; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  JCI Insight       Date:  2016-09-22

6.  Tumor necrosis factor production in patients with leprosy.

Authors:  P F Barnes; D Chatterjee; P J Brennan; T H Rea; R L Modlin
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Divergence of macrophage phagocytic and antimicrobial programs in leprosy.

Authors:  Dennis Montoya; Daniel Cruz; Rosane M B Teles; Delphine J Lee; Maria Teresa Ochoa; Stephan R Krutzik; Rene Chun; Mirjam Schenk; Xiaoran Zhang; Benjamin G Ferguson; Anne E Burdick; Euzenir N Sarno; Thomas H Rea; Martin Hewison; John S Adams; Genhong Cheng; Robert L Modlin
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

8.  Immunohistochemical staining of macrophages in the skin lesions of leprosy: the role of antibody to mycobacteria in human serum and various polyclonal immune rabbit antisera.

Authors:  H J Kahn; P Thorner; R Baumal; H Yeger; D Bailey; A Marks; L From; B K Fisher; C Lynde
Journal:  Histochem J       Date:  1985-09

9.  Selection of T lymphocytes bearing limited T-cell receptor beta chains in the response to a human pathogen.

Authors:  X H Wang; J D Ohmen; K Uyemura; T H Rea; M Kronenberg; R L Modlin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

10.  Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization.

Authors:  C L Cooper; C Mueller; T A Sinchaisri; C Pirmez; J Chan; G Kaplan; S M Young; I L Weissman; B R Bloom; T H Rea; R L Modlin
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.